1) Akechi T, Nakano T, Akizuki N, et al:Somatic symptoms for diagnosing major depression in cancer patients. Psychosomatics 44:244-248, 2003
2) Davis MP, Walsh D:Treatment of nausea and vomiting in advanced cancer. Support Care Cancer 8:578-581, 2003
3) Jackson WC, Tavernier L:Olanzapine for intractable nausea in palliative care patients. J Palliat Med 6:251-255, 2003
4) Navari RM, Einhorn LH, Passik SD, et al:A phaseⅡtrial of olanzapine for the prevention of chemotherapy-induced nausea and vomiting:A Hoosier Oncology Group Study. Support Care Cancer 13:529-534, 2005
5) Passik SD, Lundberg J, Kirsh KL, et al:A pilot exploration of the antiemetic activity of olanzapine for the relief of nausea in patients with advanced cancer and pain. J Pain Symptom Manage 23:526-532, 2002
6) Passik SD, Navari RM, Jung SH, et al:A phaseⅠtrial of olanzapine(Zyprexa)for the prevention of delayed emesis in cancer patients:A Hoosier Oncology Group Study. Cancer Invest 22:383-388, 2004
7) Sharma R, Tobin P, Clarke SJ:Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhoea. Lancet Oncol 6:93-102, 2005
8) Srivastava M, Brito-Dellan N, Davis MP, et al:Olanzapine as an antiemetic in refractory nausea and vomiting in advanced cancer. J Pain Symptom Manage 25:578-582, 2003
9) (財)日本医薬情報センター:クエン酸フェンタニル. Drugs in Japan. pp1768-1770, 2003